熱門資訊> 正文
Bioceres报告第四季度业绩
2025-09-09 18:08
- Bioceres press release (NASDAQ:BIOX): Q4 net loss was $48.0 million and Adjusted EBITDA1 was negative $4.5 million. For FY25, operating loss was $3.7 million, net loss was $55.2 million and Adjusted EBITDA1 was $28.3 million.
- Revenue of $74.7M (-39.8% Y/Y) misses by $35.38M.
- Net cash flow generated by operating activities reached $29.9 million in 4Q25, and $53.0 million in FY25, a 27% YoY increase from FY24.
More on Bioceres
- Seeking Alpha’s Quant Rating on Bioceres
- Historical earnings data for Bioceres
- Financial information for Bioceres
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
